California Institute for Regenerative Medicine

The quarterly Venture Monitor report from Pitchbook and the National Venture Capital Association (NVCA) reported biopharma start-ups raised $5.9bn in the first quarter of 2024 – more than the sector r

Scion Life Sciences, an affiliate of the health care investment firm Petrichor, launched on 7 February with two friends and former Apple Tree Partners (ATP) colleagues – Scion co-founders and managing

Emalex Biosciences Inc. significantly expanded on its previous capacity to fund the upcoming Phase III clinical trial of ecopipam in Tourette’s syndrome with a $250m series D financing barely a year